These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31032968)

  • 1. Response to random apheresis platelets versus HLA-selected platelets versus pooled platelets in HLA-sensitized patients.
    Gavva C; Barroso J; Gernsheimer T; Metcalf RA; Warner P; Pagano MB
    Transfusion; 2019 Jul; 59(7):2276-2281. PubMed ID: 31032968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients.
    Mirlashari MR; Vetlesen A; Nissen-Meyer LSH; Naper C; Tjønnfjord GE; Njerve IU; Ezligini F; Landmark BF; Meinke S; Sandgren P; Höglund P; Hetland G
    Transfusion; 2021 Apr; 61(4):1222-1234. PubMed ID: 33580979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
    Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J
    Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen (HLA)-incompatible mean fluorescence intensity-selected platelet products have corrected count increments similar to HLA antigen-matched platelets.
    Karafin MS; Schumacher C; Zhang J; Simpson P; Johnson ST; Pierce KL
    Transfusion; 2021 Aug; 61(8):2307-2316. PubMed ID: 34075590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome.
    Khatri SS; Curtis BR; Yamada C
    Immunohematology; 2019 Dec; 35(4):139-144. PubMed ID: 31935329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.
    Honohan A; Tomson B; van der Bom J; de Vries R; Brand A
    Transfusion; 2012 Apr; 52(4):742-51. PubMed ID: 21981629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
    Seike K; Fujii N; Asano N; Ohkuma S; Hirata Y; Fujii K; Sando Y; Nakamura M; Naito K; Saeki K; Meguri Y; Asada N; Ennishi D; Nishimori H; Matsuoka KI; Tsubaki K; Otsuka F; Maeda Y
    Transfusion; 2020 Mar; 60(3):473-478. PubMed ID: 31970799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy of shipped HLA-matched platelets.
    Haddad SA; Lichtiger B; Klein HG
    Transfusion; 2006 Aug; 46(8):1306-10. PubMed ID: 16934064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
    Weisberg SP; Shaz BH; Tumer G; Silliman CC; Kelher MR; Cohn CS
    Transfusion; 2018 Apr; 58(4):891-895. PubMed ID: 29473178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
    Eder AF; Dy BA; O'Neill EM
    Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.
    Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC
    J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation.
    Vetlesen A; Holme PA; Lyberg T; Kjeldsen-Kragh J
    Transfusion; 2012 Jun; 52(6):1321-32. PubMed ID: 22084943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
    Figueiredo C; Blaszczyk R
    J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
    Friedberg RC; Donnelly SF; Mintz PD
    Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.